Atypical complication in an adult patient with dengue and autoimmune hemolytic anemia: a case report

[1] Srichaikul T, Nimmannitya S. Haematology in dengue and dengue haemorrhagic fever. Baillieres Best Pract Res Clin Haematol. 2000; 13:261–76. SrichaikulT NimmannityaS Haematology in dengue and dengue haemorrhagic fever Baillieres Best Pract Res Clin Haematol 2000 13 261 76 10.1053/beha.2000.007310942625 Search in Google Scholar

[2] Chuansumrit A, Wangruangsatid S, Lektrakul Y, Chua MN, Zeta Capeding MR, Bech OM; Dengue Study Group. Control of bleeding in children with Dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study. Blood Coagul Fibrinolysis. 2005; 16:549–55. ChuansumritA WangruangsatidS LektrakulY ChuaMN Zeta CapedingMR BechOM Dengue Study Group Control of bleeding in children with Dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study Blood Coagul Fibrinolysis 2005 16 549 55 10.1097/01.mbc.0000186837.78432.2f16269927 Search in Google Scholar

[3] Verdeal JC, Costa Filho R, Vanzillotta C, Macedo GL, Bozza FA, Toscano L, et al. Guidelines for the management of patients with severe forms of dengue. Rev Bras Ter Intensiva. 2011; 23:125–33. [Article in English, Portuguese] VerdealJC Costa FilhoR VanzillottaC MacedoGL BozzaFA ToscanoL Guidelines for the management of patients with severe forms of dengue Rev Bras Ter Intensiva 2011 23 125 33 [Article in English, Portuguese] 10.1590/S0103-507X2011000200004 Search in Google Scholar

[4] Chamnanchanunt S, Kanagaraj D, Thanachartwet V, Desakorn V, Rojnuckarin P. Early predictors of clinically significant bleeding in adults with dengue infection. Southeast Asian J Trop Med Public Health. 2012; 43:890–9. ChamnanchanuntS KanagarajD ThanachartwetV DesakornV RojnuckarinP Early predictors of clinically significant bleeding in adults with dengue infection Southeast Asian J Trop Med Public Health 2012 43 890 9 Search in Google Scholar

[5] Cavalcanti LPdG, Braga DNdM, Pompeu MMdL, Lima AAB, Silva LMAd, Aguiar MG, et al. Evaluation of the World Health Organization 2009 classification of dengue severity in autopsied individuals, during the epidemics of 2011 and 2012 in Brazil. Rev Soc Bras Med Trop. 2015; 48:658–64. CavalcantiLPdG BragaDNdM PompeuMMdL LimaAAB SilvaLMAd AguiarMG Evaluation of the World Health Organization 2009 classification of dengue severity in autopsied individuals, during the epidemics of 2011 and 2012 in Brazil Rev Soc Bras Med Trop 2015 48 658 64 10.1590/0037-8682-0287-201526676489 Search in Google Scholar

[6] Goodnough LT, Lublin DM, Zhang L, Despotis G, Eby C. Transfusion medicine service policies for recombinant factor VIIa administration. Transfusion. 2004; 44:1325–31. GoodnoughLT LublinDM ZhangL DespotisG EbyC Transfusion medicine service policies for recombinant factor VIIa administration Transfusion 2004 44 1325 31 10.1111/j.1537-2995.2004.04052.x15318856 Search in Google Scholar

[7] Chaudhary RK, Das SS. Autoimmune hemolytic anemia: from lab to bedside. Asian J Transfus Sci. 2014; 8:5–12. ChaudharyRK DasSS Autoimmune hemolytic anemia: from lab to bedside Asian J Transfus Sci 2014 8 5 12 10.4103/0973-6247.126681394314824678166 Search in Google Scholar

[8] Dutta TK, Verma SP. Rational use of recombinant factor VIIa in clinical practice. Indian J Hematol Blood Transfus. 2014; 30:85–90. DuttaTK VermaSP Rational use of recombinant factor VIIa in clinical practice Indian J Hematol Blood Transfus 2014 30 85 90 10.1007/s12288-013-0240-9402291824839361 Search in Google Scholar

[9] Oka S, Shiragami H, Nohgawa M. Intravascular hemolytic anemia in a patient with antibodies related to meropenem. Intern Med. 2015; 54:1291–5. OkaS ShiragamiH NohgawaM Intravascular hemolytic anemia in a patient with antibodies related to meropenem Intern Med 2015 54 1291 5 10.2169/internalmedicine.54.338525986273 Search in Google Scholar

[10] Zanella A, Barcellini W. Treatment of autoimmune hemolytic anemias. Haematologica. 2014; 99:1547–54. ZanellaA BarcelliniW Treatment of autoimmune hemolytic anemias Haematologica 2014 99 1547 54 10.3324/haematol.2014.114561418125025271314 Search in Google Scholar

[11] Jaime-Peréz JC, Rodríguez-Martínez M, Gómez-de-León A, Tarín-Arzaga L, Gómez-Almaguer D. Current approaches for the treatment of autoimmune hemolytic anemia. Arch Immunol Ther Exp (Warsz). 2013; 61:385–95. Jaime-PerézJC Rodríguez-MartínezM Gómez-de-LeónA Tarín-ArzagaL Gómez-AlmaguerD Current approaches for the treatment of autoimmune hemolytic anemia Arch Immunol Ther Exp (Warsz) 2013 61 385 95 10.1007/s00005-013-0232-323689532 Search in Google Scholar

[12] Berentsen S, Tjønnfjord GE. Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood Rev. 2012; 26:107–15. BerentsenS TjønnfjordGE Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia Blood Rev 2012 26 107 15 10.1016/j.blre.2012.01.00222330255 Search in Google Scholar

[13] King KE, Ness PM. Treatment of autoimmune hemolytic anemia. Semin Hematol. 2005; 42:131–6. KingKE NessPM Treatment of autoimmune hemolytic anemia Semin Hematol 2005 42 131 6 10.1053/j.seminhematol.2005.04.00316041662 Search in Google Scholar